​

Funding Round

Series A - Enveda Biosciences

Series A - Enveda Biosciences

Investment Firm

Overview

Enveda Biosciences is a biotechnology company engineering new drugs from plants.

Announced Date

Jun 22, 2021

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Lux Capital

Lux Capital

Lux Capital is a debt and early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

Participant Investors

10

Investor Name
Participant InvestorWireframe Ventures
Participant InvestorLux Capital
Participant InvestorTwo Sigma Ventures
Participant InvestorHummingbird Ventures
Participant InvestorTrue Ventures

Round Details and Background

Enveda Biosciences raised $51000000 on 2021-06-22 in Series A

Enveda Biosciences is a biotechnology company engineering new drugs from plants.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 21, 2022
Series B - Enveda Biosciences
12-55.0M
Dec 21, 2022
Debt Financing - Enveda Biosciences
1-13.0M
Apr 20, 2023
Series B - Enveda Biosciences
6-51.0M
Jun 14, 2024
Series B - Enveda Biosciences
9-55.0M

Recent Activity

There is no recent news or activity for this profile.